FOSUN PHARMA (02196.HK) Latest Stock News - Major News Analysis - Longbridge

Quote List Quote List

Event Tracking

Dec30

Fosun Pharmaceutical's Subsidiary Kicks Off Phase I Clinical Trial for SRT-007 Prostate Cancer Radiopharmaceutical

11:23

Dec29

Fosun Pharma Plans to Acquire Green Valley Pharmaceutical for 1.412 Billion to Integrate Innovative Drug Pipeline

14:18

Dec23

Fosun Pharma Aims to Acquire 75% Equity of Green Valley Pharmaceutical for 1.412 Billion Yuan

19:12

Fosun Pharma Acquires Green Valley Pharmaceuticals Controlling Stake and Supports Clinical Trials for Gantenerumab Capsules

00:07

Fosun Pharma Discloses Sales Data and Clinical Trial Progress of 971

00:01

Dec19

Fosun Pharma Aims to Acquire Green Valley for Continued Clinical Trials of 'Nine-Seven-One'

00:18

Schedules & Filings

Schedules

Filings

Oct28

Earning Release(CST)

FY2025 Q3 Earning Release (HKD) Revenue 10.8 B, Net Income 897.85 M, EPS 0.3388

Aug26

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 11.05 B, Net Income 1.026 B, EPS 0.3825

Aug22

Distribution Plan(CST)

Cash dividend 0.35 HKD

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More